Multiparametric Ultrasound (mpUS) as Imaging Modality for the Detection and Localization of Prostate Cancer

Recruiting

• Conditions: prostate cancer; prostate carcinoma; 10038597

• Registration Number: NL-OMON45386
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

- Patients * 18 years old
- Biopsy proven prostate carcinoma
- Treatment by (robot laparoscopic) radical prostatectomy
- Signed informed consent

Exclusion Criteria

- Patients < 18 years old
- Chemotherapy and/or radiotherapy for prostate cancer
- Hormonal therapy for prostate cancer within 6 months prior to procedure
- Patients with known allergy for Sonovue
- Patients with severe cardiac problems: right-to-left cardiac shunt and/or severe (pulmonal) hypertension and/or use of dobutamine medication
- Patients with Acute Respiratory Distress Syndrome

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To directly correlate and compare mpUS imaging and its parameters with the<br /><br>histology of the resected prostate.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary study parameters are summarized in the Protocol paper, section 8.<br /><br>Methods, pag 27 of 42.</p><br>